Business Context and Reporting Period
Company: James Hardie Industries Plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2019
Filing Date: June 10, 2019
This filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The document primarily contains forward-looking statements and an exhibit index regarding a dividend/distribution update.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing referencing other reports for financial details.
Material Changes
No material changes to financial performance or operations are detailed in this specific text. The filing references an "Update - Dividend/Distribution - JHX" in Exhibit 99.3, but the specific terms or amounts of this update are not included in the provided content.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes an extensive disclaimer regarding forward-looking statements. These statements cover future performance, operational results, strategic plans, capital expenditures, credit facilities, dividends, share buy-backs, tax structures, and legal proceedings.
Key Risks Identified:
- Liabilities related to prior manufacture of asbestos-containing products and contributions to the Asbestos Injuries Compensation Fund (AICF).
- Currency exchange rate fluctuations affecting asbestos liabilities and financial statements.
- Compliance with tax laws and potential tax charges.
- Market competition, product pricing, and product failures.
- Legal proceedings including environmental, asbestos, and consumer class actions.
- General economic conditions, housing market recovery, and construction levels in the US and Asia Pacific.
- Raw material supply and costs.
- Integration of Fermacell into the business.
Management Commentary: Management cautions that actual results may differ materially from anticipated results due to inherent risks and uncertainties. The company assumes no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the specific details of the dividend or distribution update referenced in Exhibit 99.3.
- Review the most recent Form 20-F for detailed financial metrics (revenue, profit, cash flow) not present in this 6-K.
- Assess the current status of the Asbestos Injuries Compensation Fund (AICF) and any recent changes to contribution estimates.
- Monitor currency exchange rate impacts on the company's reported liabilities.
- Check for updates on the integration of Fermacell and any associated capital expenditure projects.